Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Revelation Biosciences Inc. (REVB)

  • Technical Exchange News
  • Feb. 08, 2024, 19:01 UTC
  • 28
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Inovio Pharmaceuticals Inc (INO)

  • Technical Exchange News
  • Feb. 08, 2024, 19:00 UTC
  • 30
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Corbus Pharmaceuticals Holdings Inc. (CRBP)

  • Technical Exchange News
  • Feb. 08, 2024, 19:00 UTC
  • 29
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cara Therapeutics (CARA)

  • Technical Exchange News
  • Feb. 08, 2024, 19:00 UTC
  • 30
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Revelation Biosciences Inc. (REVB)

  • Technical Exchange News
  • Feb. 08, 2024, 18:42 UTC
  • 28
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Inovio Pharmaceuticals Inc (INO)

  • Technical Exchange News
  • Feb. 08, 2024, 18:42 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Corbus Pharmaceuticals Holdings Inc. (CRBP)

  • Technical Exchange News
  • Feb. 08, 2024, 18:41 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cara Therapeutics (CARA)

  • Technical Exchange News
  • Feb. 08, 2024, 18:41 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

InVitae Corp (NVTA)

  • Technical Exchange News
  • Feb. 07, 2024, 00:16 UTC
  • 29
  • 0 comments

IEXG symbol attribute type Test_mode was changed. Previous value: Y. New value: Invitae Corporation Common Stock.

Comment Full text

InVitae Corp (NVTA)

  • Technical Exchange News
  • Feb. 07, 2024, 00:16 UTC
  • 30
  • 0 comments

IEXG symbol attribute type Security_Name was changed. Previous value: IEX Test Company Test Symbol Three for IEX. New value: Invitae Corporation Common Stock.

Comment Full text
  • Previous
  • 685
  • 686
  • 687
  • 688
  • 689
  • Next

Search

News categories

  • Technical Exchange News(10969)
  • Event(2433)
  • SEC News(193301)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125822)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin